Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination.
JournalFrontiers in Immunology
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractBiomaterial delivery systems offer unique potential to improve cancer vaccines by offering targeted delivery and modularity to address disease heterogeneity. Here, we develop a simple platform using a conserved human melanoma peptide antigen (Trp2) modified with cationic arginine residues that condenses an anionic toll-like receptor agonist (TLRa), CpG, into polyplex-like nanoparticles. We reasoned that these structures could offer several useful features for immunotherapy – such as tunable loading, co-delivery of immune cues, and cargo protection – while eliminating the need for synthetic polymers or other complicating delivery systems. We demonstrate that Trp2/CpG polyplexes can readily form over a range of Trp2:CpG ratios and improve antigen uptake by primary antigen presenting cells. We show antigen loading can be tuned by interchanging Trp2 peptides with defined charges and numbers of arginine residues. Notably, these polyplexes with greater antigen loading enhance the functionality of Trp-2 specific T cells and in a mouse melanoma model, decrease tumor burden and improve survival. This work highlights opportunities to control the biophysical properties of nanostructured materials built from immune signals to enhance immunotherapy, without the added complexity or background immune effects often associated with synthetic carriers.
Rights/TermsCopyright © 2021 Tsai, Amerman and Jewell.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14701
- Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
- Authors: Goforth R, Salem AK, Zhu X, Miles S, Zhang XQ, Lee JH, Sandler AD
- Issue date: 2009 Apr
- Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
- Authors: Xu Z, Ramishetti S, Tseng YC, Guo S, Wang Y, Huang L
- Issue date: 2013 Nov 28
- Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy.
- Authors: Su Q, Wang C, Song H, Zhang C, Liu J, Huang P, Zhang Y, Zhang J, Wang W
- Issue date: 2021 May 12
- Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
- Authors: Li H, Li Y, Wang X, Hou Y, Hong X, Gong T, Zhang Z, Sun X
- Issue date: 2017
- The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
- Authors: Lai C, Duan S, Ye F, Hou X, Li X, Zhao J, Yu X, Hu Z, Tang Z, Mo F, Yang X, Lu X
- Issue date: 2018